Coinbase Global, Inc. (BMV:COIN)

Longboard Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	6,706	6,293	2,927	3,149	7,355	1,141
Other Revenue	-	-	-	-	482.55	133.69
Revenue	6,706	6,293	2,927	3,149	7,837	1,275
Revenue Growth (YoY)	49.18%	115.04%	-7.06%	-59.82%	514.76%	143.85%
Cost of Revenue	1,037	897.71	420.71	629.88	1,268	135.51
Gross Profit	5,669	5,396	2,506	2,519	6,569	1,139
Selling, General & Admin	2,315	1,955	1,382	2,111	1,526	335.56
Research & Development	1,489	1,468	1,325	2,326	1,291	271.73
Other Operating Expenses	-24.07	-63.79	-24.42	796.8	477.15	124.62
Operating Expenses	3,780	3,359	2,682	5,234	3,294	731.92
Operating Income	1,889	2,036	-175.91	-2,715	3,275	407.43
Interest Expense	-82.11	-80.65	-82.77	-88.9	-29.16	-
Interest & Investment Income	302.29	270.78	181.84	45.39	2.14	2.63
Currency Exchange Gain (Loss)	-2.49	-2.49	-10.61	-161.75	-40.99	-1.06
Other Non Operating Income (Expenses)	191.13	728.31	36.38	-2.51	-181.17	4.59
EBT Excluding Unusual Items	2,298	2,952	-51.06	-2,923	3,026	413.58
Merger & Restructuring Charges	-	-	-142.59	-40.7	-8	-1.1
Gain (Loss) on Sale of Investments	1,480	-9.69	24.43	-101.22	48.54	-
Asset Writedown	-	-	-	-	-0.5	-
Other Unusual Items	-306.65	-	92.38	-	-39.2	-3.28
Pretax Income	3,472	2,943	-76.85	-3,065	3,027	409.2
Income Tax Expense	610.51	363.58	-171.72	-439.63	-597.17	86.88
Net Income	2,861	2,579	94.87	-2,625	3,624	322.32
Preferred Dividends & Other Adjustments	0.53	1.31	0.12	-	527.16	214.06
Net Income to Common	2,861	2,578	94.75	-2,625	3,097	108.26
Net Income Growth	92.86%	2618.50%	-	-	1024.40%	-
Shares Outstanding (Basic)	252	247	236	222	177	69
Shares Outstanding (Diluted)	277	273	254	222	220	91
Shares Change (YoY)	1.42%	7.46%	14.42%	1.08%	141.17%	48.75%
EPS (Basic)	11.34	10.42	0.40	-11.81	17.47	1.58
EPS (Diluted)	10.37	9.48	0.37	-11.83	14.50	1.40
EPS Growth	90.38%	2444.87%	-	-	937.81%	-
Free Cash Flow	1,807	2,557	922.95	-1,585	4,038	283.64
Free Cash Flow Per Share	6.52	9.35	3.63	-7.13	18.36	3.11
Gross Margin	84.54%	85.73%	85.62%	80.00%	83.82%	89.37%
Operating Margin	28.17%	32.36%	-6.01%	-86.22%	41.79%	31.96%
Profit Margin	42.66%	40.96%	3.24%	-83.36%	39.52%	8.49%
Free Cash Flow Margin	26.94%	40.63%	31.54%	-50.35%	51.52%	22.25%
EBITDA	2,020	2,164	-36.27	-2,561	3,339	438.39
EBITDA Margin	30.12%	34.38%	-1.24%	-81.33%	42.60%	34.39%
D&A For EBITDA	130.92	127.52	139.64	154.07	63.65	30.96
EBIT	1,889	2,036	-175.91	-2,715	3,275	407.43
EBIT Margin	28.17%	32.36%	-6.01%	-86.22%	41.79%	31.96%
Effective Tax Rate	17.59%	12.35%	-	-	-	21.23%
Revenue as Reported	7,008	6,564	3,108	3,194	7,839	1,277

Source: S&P Global Market Intelligence. Standard template. Financial Sources.